Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Penumbra (PEN)

Penumbra Q1 revenue rises 15.4% to $278.7 million; 2024 guidance reiterated

Positive Impact 3 of 5 earnings Written later

Penumbra reported first-quarter 2024 revenue of $278.7 million, up 15.4% from a year earlier, and GAAP net income of $11.0 million, or $0.28 per diluted share, compared with $8.6 million, or $0.22, in the first quarter of 2023. The company reiterated its full-year 2024 revenue guidance of $1,230.0 million to $1,270.0 million, which reflects 16% to 20% growth.

Key points

  • Revenue of $278.7 million, up 15.4% from $241.4 million; U.S. revenue rose 22.0% while international revenue fell 0.7%.
  • GAAP net income of $11.0 million, or $0.28 per diluted share, versus $8.6 million, or $0.22, a year earlier.
  • Operating expenses included $4.8 million in non-recurring litigation-related expenses in the first quarter of 2024.
  • Full-year 2024 total revenue guidance of $1,230.0 million to $1,270.0 million was reiterated, and U.S. thrombectomy growth guidance of 27% to 30% was also kept.

The filing

CompanyPenumbra (PEN)
Form8-K, current report
Filed with the SECMay 7, 2024, 4:14 PM ET
Accession number0001321732-24-000058

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.